XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.23.3

Derivatives (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The fair value of derivative instruments on a gross basis was as follows on the dates indicated (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Fair Value of Derivative Instruments Designated as Hedging Instruments |  | Balance Sheet Location |  | September 30, 2023 |  | December 31, 2022
Assets |  |  |  | ​ |  |  | ​ |
Interest rate swaps |  | Prepaid expenses and other assets | ​ | $ | 2,320 | ​ | $ | —
Interest rate swaps |  | Other assets (long-term) | ​ | ​ | — | ​ | ​ | 3,444
Foreign currency forward contracts |  | Prepaid expenses and other assets | ​ | ​ | 3,463 | ​ | ​ | 3,215
Foreign currency forward contracts |  | Other assets (long-term) | ​ | ​ | 698 | ​ |  | 56
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(Liabilities) |  |  | ​ |  |  | ​ |  |
Foreign currency forward contracts |  | Accrued expenses | ​ |  | (845) | ​ |  | (1,509)
Foreign currency forward contracts |  | Other long-term obligations | ​ |  | (238) | ​ |  | (531)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Fair Value of Derivative Instruments Not Designated as Hedging Instruments |  | Balance Sheet Location |  | September 30, 2023 |  | December 31, 2022
Assets |  |  | ​ |  |  | ​ |  |
Foreign currency forward contracts |  | Prepaid expenses and other assets | ​ | $ | 1,874 | ​ | $ | 1,512
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(Liabilities) |  |  | ​ |  |  | ​ |  |
Foreign currency forward contracts |  | Accrued expenses | ​ |  | (1,897) | ​ |  | (1,946)
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) | Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on other comprehensive income (“OCI”), accumulated other comprehensive income (“AOCI”), and net earnings in our consolidated statements of income, consolidated statements of comprehensive income and consolidated balance sheets (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount of Gain/(Loss) | ​ | ​ | ​ | Consolidated Statements | ​ | Amount of Gain/(Loss)
​ | ​ | Recognized in OCI | ​ | ​ | ​ | of Income | ​ | Reclassified from AOCI
​ | ​ | Three Months Ended September 30, |  | ​ |  | Three Months Ended September 30, | ​ | Three Months Ended September 30,
Derivative instrument |  | 2023 |  | 2022 |  | Location in statements of income |  | 2023 |  |  | 2022 |  | 2023 |  |  | 2022
Interest rate swaps | ​ | $ | 126 | ​ | $ | 1,504 | ​ | Interest expense | ​ | $ | (4,841) | ​ | $ | (1,831) | ​ | $ | 685 | ​ | $ | 94
Foreign currency forward contracts | ​ |  | 1,503 | ​ |  | 3,491 | ​ | Revenue | ​ |  | 315,230 | ​ |  | 287,175 | ​ |  | 866 | ​ |  | 1,491
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Cost of sales | ​ |  | (173,031) | ​ |  | (158,602) | ​ |  | 617 | ​ |  | (440)
​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Amount of Gain/(Loss) | ​ | ​ | Consolidated Statements | ​ | Amount of Gain/(Loss) | ​
​ | ​ | Recognized in OCI | ​ | ​ | of Income | ​ | Reclassified from AOCI | ​
​ | ​ | Nine Months Ended September 30, | ​ | ​ | Nine Months Ended September 30, | ​ | Nine Months Ended September 30, |
Derivative instrument |  | 2023 |  | 2022 |  | Location in statements of income |  | 2023 |  | ​ | 2022 |  | 2023 |  |  | 2022 |
Interest rate swaps | ​ | $ | 726 | ​ | $ | 4,507 | ​ | Interest expense | ​ | $ | (10,534) | ​ | $ | (4,180) | ​ | $ | 1,850 | ​ | $ | (379) | ​
Foreign currency forward contracts | ​ |  | 6,067 | ​ |  | 8,713 | ​ | Revenue | ​ |  | 932,851 | ​ |  | 857,566 | ​ |  | 2,851 | ​ |  | 1,303 | ​
​ | ​ | ​ | ​ | Cost of sales | ​ |  | (499,508) | ​ |  | (473,019) | ​ |  | 900 | ​ |  | (886) | ​
Derivative Instruments, Gain (Loss) | The following gains/(losses) from these derivative instruments were recognized in our consolidated statements of income for the periods presented (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Three Months Ended September 30, |  | Nine Months Ended September 30, |
Derivative Instrument |  | Location in statements of income |  | 2023 |  | 2022 |  | 2023 |  | 2022 |
Foreign currency forward contracts |  | Other income (expense) — net | ​ | $ | (452) | ​ | $ | 1,034 | ​ | $ | 2,748 | ​ | $ | 1,212 | ​
​

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C + Details
Name: | us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration